CDC Warns of New COVID Variant Spreading Rapidly Across US
The CDC warns that a new COVID variant, BA.3.2, is spreading rapidly in several countries and parts of the U.S. Public health researchers shared findings in a recent CDC report. The Centers for Disease Control and Prevention published data in the Morbidity and Mortality Weekly Report.
As of Feb. 11, at least 23 countries had reported BA.3.2, according to the CDC study. The variant was tracked through the agency’s Traveler-Based Genomic Surveillance program.
Genetic features and immune escape
BA.3.2 carries roughly 70 to 75 changes in its spike protein gene sequence. Those alterations affect the structure the virus uses to enter human cells.
Researchers describe immune escape characteristics in BA.3.2. These mutations may partially reduce protection from vaccines or past infection. Experts say that could increase infection risk but not necessarily disease severity.
Detection timeline and geographic spread
BA.3.2 first appeared in U.S. surveillance in June 2025. The initial U.S. case involved a traveler arriving from the Netherlands.
The variant began rising globally in September 2025. From November 2025 through January 2026, weekly detections reached about 30 percent of samples in Denmark, Germany and the Netherlands.
| Type of detection | Count |
|---|---|
| Nasal swabs from U.S. travelers | 4 |
| Clinical patient samples | 5 |
| Airplane wastewater samples | 3 |
| Wastewater surveillance samples | 132 (from 25 states) |
Viral evolution and sublineages
Phylogenetic analysis has identified two BA.3.2 sublineages, labeled BA.3.2.1 and BA.3.2.2. This indicates ongoing viral evolution.
Authors note BA.3.2 is genetically distinct from JN.1 lineages. Those JN.1 lineages include variants such as LP.8.1 and XFG, which circulated in the United States since January 2024.
Surveillance and public health implications
Researchers warned that reported detections may understate true prevalence. Many countries have limited genomic sequencing and surveillance capacity.
The CDC called for continued genomic surveillance to track BA.3.2’s evolution. Ongoing monitoring will help assess potential impacts on public health measures and vaccines.
Filmogaz.com will follow developments and report updates as more data become available. Public health agencies recommend staying up to date with vaccinations and monitoring official guidance.
